Nature's Ozempic? Two Botanical Extracts Show Stunning Weight Loss Results in New Study

The conversation around weight loss has been completely reshaped by a class of drugs known as GLP-1 agonists, like semaglutide (Ozempic, Wegovy). Their ability to regulate appetite and promote significant weight loss has made them household names. But what if the next leap forward in metabolic health wasn't found in a pharmacy, but in the ancient wisdom of traditional botany?

A groundbreaking clinical trial published in the peer-reviewed journal Medicina has put two patented botanical extracts in the spotlight, suggesting they may offer a natural pathway to similar, remarkable results. The study found that Dyglomera (Dichrostachys glomerata) and CQR-300 (Cissus quadrangularis) delivered significant weight management benefits, positioning them as powerful contenders in the fight against obesity.

The New Frontier: GLP-1 and DPP-4 Explained

To understand why this study is so exciting, we need to talk about two key players in your body's metabolic signaling system: GLP-1 and DPP-4.

GLP-1 (Glucagon-like peptide-1) is an incretin hormone produced in your gut after you eat. Think of it as your body's natural appetite suppressant and blood sugar regulator. It signals to your brain that you're full, slows down how quickly your stomach empties, and helps your pancreas release the right amount of insulin. More GLP-1 activity generally means better appetite control and improved metabolic health.

DPP-4 (Dipeptidyl peptidase-4) is an enzyme that acts as the "off switch" for GLP-1. Its job is to break down and deactivate GLP-1, limiting its effects. If you can reduce the activity of DPP-4, GLP-1 can stick around longer to do its job, enhancing feelings of fullness and supporting weight management.

This is precisely the mechanism targeted by many popular weight loss drugs. Now, it seems two plant extracts might achieve a similar outcome naturally.

Unpacking the Groundbreaking Clinical Trial

This wasn't just a small, preliminary test. Researchers conducted a robust, 16-week randomized, double-blind, placebo-controlled trial—the gold standard in clinical research. The study involved 248 overweight or obese adults who were divided into four groups:

1. Dyglomera (DGE) Group: Received 400 mg daily.
2. CQR-300 (CQE) Group: Received 300 mg daily.
3. Semaglutide Group: Received a standard oral dose for comparison.
4. Placebo Group: Received an inactive pill.

Crucially, participants were not asked to change their diet or exercise habits. The researchers measured changes in GLP-1 levels, DPP-4 activity, body weight, body fat, calorie intake, and feelings of satiety over the four-month period.

The Stunning Results: How Did the Botanicals Stack Up?

The findings were nothing short of remarkable. Both botanical extracts demonstrated powerful effects on metabolism and body composition, proving to be far superior to the placebo and surprisingly comparable to the pharmaceutical option.

Dyglomera (Dichrostachys glomerata): A Potent Metabolic Modulator

Participants taking the Dyglomera extract, a polyphenol-rich plant traditionally used in Africa, experienced significant improvements across the board. By the end of the 16-week trial, the DGE group showed:

• A 5.2% reduction in total body weight.
• A massive 10.3% decrease in body fat.
• A 38.6 pg/mL increase in circulating GLP-1 levels.
• A 15.3% reduction in DPP-4 activity, allowing GLP-1 to work more effectively.
• A 16.2% decrease in daily energy intake, indicating participants naturally ate less.
• A 25.6% increase in satiety, meaning they felt fuller and more satisfied.

CQR-300 (Cissus quadrangularis): An Ancient Vine with Modern Power

The group taking CQR-300, an extract from a vine long used in traditional Asian and African medicine, saw even slightly more pronounced results in some areas. The CQE group achieved:

• A 5.8% reduction in total body weight.
• An impressive 10.9% drop in body fat.
• A 42.2 pg/mL increase in GLP-1 levels.
• A 17.8% reduction in DPP-4 activity.
• A 17.5% reduction in daily caloric intake.
• A 27.4% boost in feelings of satiety.

These findings are poised to shake up the supplement industry, highlighting the power of specific, science-backed botanicals for metabolic health. While formulators work to bring these exact extracts to market, many are already seeking comprehensive solutions for their weight management goals. For more targeted support in this area, you can read our full expert review on Trimology.

For context, the placebo group lost only a negligible amount of weight and saw just a 5.3% increase in satiety. The semaglutide group, the pharmaceutical benchmark, experienced a 46.8 pg/mL increase in GLP-1 and a 23.5% decrease in DPP-4 activity, leading to a 4.8 kg (approx. 5-6%) body weight reduction. The results clearly show that both Dyglomera and CQR-300 performed in the same league as the well-established drug.

What This Means for the Future of Natural Weight Loss

This study is a landmark for natural health, providing strong evidence that specific botanical compounds can influence the same powerful metabolic pathways as blockbuster pharmaceuticals. It validates the traditional use of these plants and provides a clear mechanism of action—GLP-1 enhancement and DPP-4 inhibition.

As lead investigator Julius Enyong Oben, PhD, stated, “We now have the strongest evidence yet that these extracts support GLP-1 activity through natural pathways in the body, helping regulate appetite, reduce body fat, and improve key markers of metabolic health.”

The researchers concluded that these findings position both Dyglomera and CQR-300 as “promising natural agents for managing obesity.” Because they are effective in low daily doses, they are ideal candidates for inclusion in a new generation of advanced supplements, functional foods, and wellness beverages.

For the millions of people seeking effective, science-backed weight management solutions without resorting to pharmaceuticals, this research opens an exciting new door. The future of weight loss may just be a little more green.

Key Takeaways

• A new 16-week clinical trial found that the botanical extracts Dyglomera (DGE) and CQR-300 (CQE) produced significant weight loss and fat loss.
• Both extracts work by naturally increasing levels of the “fullness” hormone GLP-1 and reducing the activity of the DPP-4 enzyme that breaks it down.
• Participants taking the extracts experienced significant reductions in body weight (up to 5.8%) and body fat (up to 10.9%), with a major increase in satiety and a natural reduction in calorie intake.
• The results were found to be comparable to a standard regimen of oral semaglutide, a leading pharmaceutical weight loss drug.
• These findings establish DGE and CQE as powerful, evidence-based natural options for obesity management and metabolic health.

---

Medical Disclaimer: The information contained in this article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting any supplementation. Individual results may vary.